GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » EV-to-EBITDA

Ergo Science (Ergo Science) EV-to-EBITDA : -2.99 (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Ergo Science EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ergo Science's enterprise value is $7.85 Mil. Ergo Science's EBITDA for the trailing twelve months (TTM) ended in Sep. 2006 was $-2.62 Mil. Therefore, Ergo Science's EV-to-EBITDA for today is -2.99.

The historical rank and industry rank for Ergo Science's EV-to-EBITDA or its related term are showing as below:

ERGN's EV-to-EBITDA is not ranked *
in the Business Services industry.
Industry Median: 9.415
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Ergo Science's stock price is $10800.00. Ergo Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2006 was $0.000. Therefore, Ergo Science's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Ergo Science EV-to-EBITDA Historical Data

The historical data trend for Ergo Science's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science EV-to-EBITDA Chart

Ergo Science Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.83 - - - -1.30

Ergo Science Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ergo Science's EV-to-EBITDA

For the Staffing & Employment Services subindustry, Ergo Science's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ergo Science's EV-to-EBITDA Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Ergo Science's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ergo Science's EV-to-EBITDA falls into.



Ergo Science EV-to-EBITDA Calculation

Ergo Science's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=7.850/-2.624
=-2.99

Ergo Science's current Enterprise Value is $7.85 Mil.
Ergo Science's EBITDA for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ergo Science  (GREY:ERGN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ergo Science's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10800.00/0.000
=N/A

Ergo Science's share price for today is $10800.00.
Ergo Science's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Ergo Science EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ergo Science's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ergo Science (Ergo Science) Business Description

Traded in Other Exchanges
N/A
Address
402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223
Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.
Executives
Citigroup Inc director 388 GREENWICH STREET, NEW YORK NY 10013
Iticorp director 399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp director ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co director 336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd director 399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines